99 Results

People

  1. Kris
    Kris
  2. Chaft
    Chaft
  3. Rusch
    Rusch
  4. Bajorin
    Bajorin
  5. Gonen
    Gonen
  6. Dang
    Dang
  7. Jones
    Jones
  8. Postow
    Postow
  9. Baselga
    Baselga
  10. Bochner
    Bochner

Groups

  1. Department of Medicine (64)
  2. Solid Tumor Oncology Division (63)
  3. Surgery (41)
  4. Thoracic Oncology (23)
  5. Survivorship Research (20)
  6. Department of Pathology and Laboratory Medicine (15)
  7. Genitourinary Oncology Service (13)
  8. Melanoma Disease Management Team (11)
  9. Center for Pancreatic Cancer Research (10)
  10. Epidemiology and Biostatistics (10)
  1. "neoadjuvant"
Formats
  1. Journal Article (57)
  2. Review (17)
  3. Meeting Abstract (12)
  4. Editorial (8)
  5. Book Section (3)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Department of Medicine (64)
  2. Solid Tumor Oncology Division (63)
  3. Surgery (41)
  4. Thoracic Oncology (23)
  5. Survivorship Research (20)
  6. Department of Pathology and Laboratory Medicine (15)

More Groups

People
  1. Jamie Chaft (16)
  2. Mark Kris (12)
  3. Valerie Rusch (9)
  4. Dean Bajorin (5)
  5. Mithat Gonen (5)
  6. Chau Dang (4)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (9)
  4. 2022 (7)
  5. 2021 (13)
  6. 2020 (7)

More Years

Publications
  1. Journal of Thoracic Oncology (14)
  2. Annals of Oncology (7)
  3. BJU International (4)
  4. Cancer (4)
  5. Journal of Translational Medicine (4)
  6. European Journal of Cancer (3)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. Wiley Blackwell (14)
  3. Oxford University Press (10)
  4. Springer (8)
  5. Lippincott Williams & Wilkins (7)
  6. Biomed Central Ltd (4)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer
    Journal Article

    Bott, M. J.; Yang, S. C.; Park, B. J.; Adusumilli, P. S.; Rusch, V. W.; Isbell, J. M.; Downey, R. J.; Brahmer, J. R.; Battafarano, R.; Bush, E.; more...
    Journal of Thoracic and Cardiovascular Surgery (2019)

    Fulltext@MSK | Save
  • Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
    Journal Article

    Luen, S. J.; Salgado, R.; Dieci, M. V.; Vingiani, A.; Curigliano, G.; Gould, R. E.; Castaneda, C.; D'Alfonso, T.; Sanchez, J.; Cheng, E.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Unmet needs in functional and nonfunctional pancreatic neuroendocrine neoplasms
    Review

    Jensen, R. T.; Bodei, L.; Capdevila, J.; Couvelard, A.; Falconi, M.; Glasberg, S.; Kloppel, G.; Lamberts, S.; Peeters, M.; Rindi, G.; more...
    Neuroendocrinology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant pertuzumab-containing regimens improve pathologic complete response rates in stage II to III HER-2/neu-positive breast cancer: A retrospective, single institution experience
    Journal Article

    Murthy, R. K.; Raghavendra, A. S.; Hess, K. R.; Fujii, T.; Lim, B.; Barcenas, C. H.; Zhang, H.; Chavez-Mac-Gregor, M.; Mittendorf, E. A.; Litton, J. K.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: A proposal for quantitative immune-related pathologic response criteria (irPRC)
    Journal Article

    Cottrell, T. R.; Thompson, E. D.; Forde, P. M.; Stein, J. E.; Duffield, A. S.; Anagnostou, V.; Rekhtman, N.; Anders, R. A.; Cuda, J. D.; Illei, P. B.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): A phase II, open-label, multicenter, multinational cardiac safety study
    Journal Article

    Swain, S. M.; Ewer, M. S.; Viale, G.; Delaloge, S.; Ferrero, J. M.; Verrill, M.; Colomer, R.; Vieira, C.; Werner, T. L.; Douthwaite, H.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Immunotherapy in surgically resectable non-small cell lung cancer
    Journal Article

    Owen, D.; Chaft, J. E.
    Journal of Thoracic Disease (2018)

    Fulltext@MSK | Save
  • The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO
    Journal Article

    Di Cosimo, S.; Campbell, C.; Azim, H. A. Jr; Galli, G.; Bregni, G.; Curigliano, G.; Criscitiello, C.; Izquierdo, M.; de la Pena, L.; Fumagalli, D.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non small cell lung cancer (NSCLC)
    Meeting Abstract

    Owen, D.; Bunn, P. Jr; Johnson, B.; Kwiatkowski, D.; Kris, M.; Wistuba, I.; Gandhi, M.; Phan, S.; Shames, D.; Schulze, K.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • The need for immune biomarkers for treatment prognosis and response in genitourinary malignancies
    Journal Article

    Slovin, S. F.
    Biomarkers in Medicine (2017)

    Fulltext@MSK | Save